Mouse monoclonal antibodies to human epithelial differentiation antigens expressed on the surface of ovarian carcinoma ascites cells
- PMID: 3677104
Mouse monoclonal antibodies to human epithelial differentiation antigens expressed on the surface of ovarian carcinoma ascites cells
Abstract
Four different human epithelial differentiation antigens (MT179, MW162, MW207, and MX35) have been defined by mouse monoclonal antibodies obtained from mice immunized with either an ovarian carcinoma cell line or fresh ovarian carcinoma cells. In an attempt to identify tissue-specific antigens restricted to ovarian epithelial cells, sections of a benign ovarian cyst were used as the initial target for screening hybridoma supernatants. The distribution of the antigens detected by these monoclonal antibodies was determined on frozen sections of 24 normal tissues and on 103 cultured cell lines of various histological types. In spite of the method used to select these monoclonal antibodies, they all reacted to some degree with normal epithelial cells in tissues other than ovary. All antibodies were unreactive with nonepithelial cells in frozen sections. These antibodies also reacted with frozen sections of most or all fresh ovarian carcinomas and benign ovarian cysts. All antibodies were unreactive with ABH, Lewis blood group-related antigens and appeared to be different in specificity from previously described well-characterized antigens of ovarian carcinoma cells. MW162 was characterized as a high-molecular-weight mucin-like molecule, and the determinant recognized is probably carbohydrate in nature. MW207 was identified as a Mr 37,000 protein. These monoclonal antibodies and 24 other previously derived antibodies that react with epithelial differentiation antigens were tested for reactivity with the surface of fresh ovarian carcinoma ascites cells and for nonreactivity with normal mesothelial cells. This assay was designed to select monoclonal antibodies that might be effective agents for i.p. therapy or radioimmunodetection of human ovarian carcinoma. Five antibodies with the desired specificity were selected; these were the four new antibodies described herein and MH99, which was characterized previously and recognizes a glycoprotein having Mr 38,000 and 29,000 subunits. The degree of heterogeneity of antigen expression on ascites carcinoma cell was dependent on the particular antigen being examined and was related to the biochemical nature of the antigen. In particular, most ABH and Lewis blood group-related antigens showed a striking degree of heterogeneity.
Similar articles
-
Monoclonal antibody against human ovarian tumor-associated antigens.J Natl Cancer Inst. 1986 May;76(5):781-91. J Natl Cancer Inst. 1986. PMID: 3517452
-
Development of two new monoclonal antibodies reactive to a surface antigen present on human ovarian epithelial cancer cells.Cancer Res. 1991 Aug 1;51(15):4012-9. Cancer Res. 1991. PMID: 1855217
-
A novel monoclonal antibody (7B10) with differential reactivity between human mammary carcinoma and normal breast.Cancer Res. 1987 Aug 15;47(16):4444-52. Cancer Res. 1987. PMID: 3607774
-
[Immunophenotypic characteristics of the epithelial cells of ovarian neoplasms].Postepy Hig Med Dosw. 1991;45(1-2):45-62. Postepy Hig Med Dosw. 1991. PMID: 1923996 Review. Polish.
-
[Possibilities for using monoclonal antibodies in diagnosis and therapy of head and neck cancers. I. Introduction and current state].HNO. 1991 Mar;39(3):82-90. HNO. 1991. PMID: 2050556 Review. German.
Cited by
-
Binding Affinity, Specificity and Comparative Biodistribution of the Parental Murine Monoclonal Antibody MX35 (Anti-NaPi2b) and Its Humanized Version Rebmab200.PLoS One. 2015 May 13;10(5):e0126298. doi: 10.1371/journal.pone.0126298. eCollection 2015. PLoS One. 2015. PMID: 25970341 Free PMC article.
-
Monoclonal antibody MX35 detects the membrane transporter NaPi2b (SLC34A2) in human carcinomas.Cancer Immun. 2008 Feb 6;8:3. Cancer Immun. 2008. PMID: 18251464 Free PMC article.
-
Immunohistochemical evaluation of epithelial ovarian carcinomas identifies three different expression patterns of the MX35 antigen, NaPi2b.BMC Cancer. 2017 May 2;17(1):303. doi: 10.1186/s12885-017-3289-2. BMC Cancer. 2017. PMID: 28464843 Free PMC article.
-
Therapeutic efficacy of α-radioimmunotherapy with different activity levels of the 213Bi-labeled monoclonal antibody MX35 in an ovarian cancer model.EJNMMI Res. 2017 Dec;7(1):38. doi: 10.1186/s13550-017-0283-2. Epub 2017 Apr 24. EJNMMI Res. 2017. PMID: 28439844 Free PMC article.
-
Automated astatination of biomolecules--a stepping stone towards multicenter clinical trials.Sci Rep. 2015 Jul 14;5:12025. doi: 10.1038/srep12025. Sci Rep. 2015. PMID: 26169786 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Other Literature Sources
Medical
Research Materials